S. Echechipía

1.3k total citations
39 papers, 978 citations indexed

About

S. Echechipía is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, S. Echechipía has authored 39 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Dermatology, 21 papers in Immunology and Allergy and 11 papers in Physiology. Recurrent topics in S. Echechipía's work include Allergic Rhinitis and Sensitization (19 papers), Contact Dermatitis and Allergies (19 papers) and Asthma and respiratory diseases (11 papers). S. Echechipía is often cited by papers focused on Allergic Rhinitis and Sensitization (19 papers), Contact Dermatitis and Allergies (19 papers) and Asthma and respiratory diseases (11 papers). S. Echechipía collaborates with scholars based in Spain, Colombia and United States. S. Echechipía's co-authors include Blanca E. García, Ana I. Tabar, José M. Rivera, L. Fernández de Corrés, María Teresa Lizaso, A. I. Tabar, S Martín, G. Bernaola, M. Audícana and Marta Ferrer and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Clinical & Experimental Allergy.

In The Last Decade

S. Echechipía

39 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Echechipía Spain 16 568 438 360 308 179 39 978
Pilar García-Ortega Spain 14 281 0.5× 182 0.4× 100 0.3× 154 0.5× 149 0.8× 36 544
Heike Röckmann Netherlands 15 202 0.4× 206 0.5× 101 0.3× 194 0.6× 186 1.0× 33 608
T Lobera Spain 12 241 0.4× 191 0.4× 111 0.3× 138 0.4× 331 1.8× 29 560
S. Erdmann Germany 15 363 0.6× 409 0.9× 103 0.3× 90 0.3× 219 1.2× 39 703
Leticia Vila Spain 14 1.2k 2.1× 377 0.9× 320 0.9× 79 0.3× 217 1.2× 35 1.4k
Setsuko Matsukura Japan 11 135 0.2× 194 0.4× 106 0.3× 117 0.4× 119 0.7× 28 571
B. B. Tan United Kingdom 13 332 0.6× 545 1.2× 143 0.4× 46 0.1× 28 0.2× 26 747
Elena Laffond Spain 15 236 0.4× 204 0.5× 194 0.5× 56 0.2× 175 1.0× 39 584
Catherine Pecquet France 13 378 0.7× 211 0.5× 87 0.2× 73 0.2× 111 0.6× 27 570
Hartmut Ständer Germany 17 182 0.3× 514 1.2× 77 0.2× 273 0.9× 42 0.2× 32 743

Countries citing papers authored by S. Echechipía

Since Specialization
Citations

This map shows the geographic impact of S. Echechipía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Echechipía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Echechipía more than expected).

Fields of papers citing papers by S. Echechipía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Echechipía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Echechipía. The network helps show where S. Echechipía may publish in the future.

Co-authorship network of co-authors of S. Echechipía

This figure shows the co-authorship network connecting the top 25 collaborators of S. Echechipía. A scholar is included among the top collaborators of S. Echechipía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Echechipía. S. Echechipía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gastaminza, Gabriel, Jorge M. Núñez‐Córdoba, M. L. Baeza, et al.. (2019). Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial. The Journal of Allergy and Clinical Immunology In Practice. 7(5). 1599–1609.e1. 35 indexed citations
2.
Arroabarren, Esozia, et al.. (2019). Association Between Component-Resolved Diagnosis of House Dust Mite Allergy and Efficacy and Safety of Specific Immunotherapy. Journal of Investigational Allergology and Clinical Immunology. 29(2). 164–167. 9 indexed citations
3.
Echechipía, S., et al.. (2015). Are all new allergens in TRUE Test® essential for a baseline set?. Contact Dermatitis. 73(3). 186–187. 1 indexed citations
4.
Vidal, Carmen, Ana I. Tabar, J. A. Navarro, et al.. (2011). Assessment of Short-Term Changes Induced by a Dermatophagoides pteronyssinus Extract on Asthmatic Patients. Randomised, Double-Blind, Placebo-Controlled Trial. Current Drug Delivery. 8(2). 152–158. 4 indexed citations
5.
Tabar, Ana I., et al.. (2011). Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy. Journal of Allergy and Clinical Immunology. 127(1). 57–63.e3. 72 indexed citations
6.
Arroabarren, Esozia, et al.. (2007). Tatuaje de henna en niños: ¿natural y temporal?. Anales del Sistema Sanitario de Navarra. 30(1). 131–4. 5 indexed citations
7.
Tabar, Ana I., María Teresa Lizaso, Blanca E. García, et al.. (2007). Double‐blind, placebo‐controlled study of Alternaria alternata immunotherapy: Clinical efficacy and safety. Pediatric Allergy and Immunology. 19(1). 67–75. 56 indexed citations
8.
Tabar, Ana I., S. Echechipía, Blanca E. García, et al.. (2005). Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. Journal of Allergy and Clinical Immunology. 116(1). 109–118. 85 indexed citations
9.
Tabar, A. I., B. Gómez, Rosa Sánchez‐Monge, et al.. (2004). Diversity of asparagus allergy: clinical and immunological features. Clinical & Experimental Allergy. 34(1). 131–136. 26 indexed citations
10.
Tabar, A. I., B. Gómez, Blanca E. García, et al.. (2002). Perspectivas de tratamiento: inmunoterapia con látex. Allergologia et Immunopathologia. 30(3). 163–170. 2 indexed citations
12.
Tabar, A. I., et al.. (1996). Anaphylaxis from cow's milk casein. Allergy. 51(5). 343–345. 13 indexed citations
13.
Tabar, A. I., et al.. (1996). Anaphylaxis from cow's milk casein. Allergy. 51(5). 343–345. 2 indexed citations
14.
Echechipía, S., Miguel Álvarez, B E García, et al.. (1995). Generalized dermatitis due to mitomycin C patch test. Contact Dermatitis. 33(6). 432–432. 10 indexed citations
15.
Rodríguez, Ana Alonso, et al.. (1994). Occupational contact dermatitis from vitamin B12. Contact Dermatitis. 31(4). 271–271. 4 indexed citations
16.
17.
Audícana, M., G. Bernaola, Inés Urrutia, et al.. (1994). Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross‐reactivity with cephalosporin. Allergy. 49(2). 108–113. 128 indexed citations
18.
Audícana, M., et al.. (1993). Contact Dermatitis From Phenylephrine. Dermatitis. 4(4). 225–228. 5 indexed citations
19.
Echechipía, S., et al.. (1992). Sensitization to chloramphenicol. Contact Dermatitis. 26(1). 66–67. 8 indexed citations
20.
Corrés, Luis Fernández de, et al.. (1991). Erythroderma after intravenous injection of methylprednisolone. Contact Dermatitis. 25(1). 68–70. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026